Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
49.1M
-
Shares change
-
-1.13M
-
Total reported value, excl. options
-
$938M
-
Value change
-
-$20.7M
-
Put/Call ratio
-
0.54
-
Number of buys
-
55
-
Number of sells
-
-51
-
Price
-
$19.11
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q3 2021
139 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q3 2021.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.1M shares
of 86.6M outstanding shares and own 56.7% of the company stock.
Largest 10 shareholders include Avidity Partners Management LP (4.82M shares), BlackRock Inc. (3.53M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.87M shares), Nantahala Capital Management, LLC (2.66M shares), BVF INC/IL (2.49M shares), BOXER CAPITAL, LLC (2.29M shares), VANGUARD GROUP INC (2.17M shares), STATE STREET CORP (2.1M shares), PFM Health Sciences, LP (1.86M shares), and CITADEL ADVISORS LLC (1.84M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.